Analyst Price Target is $1,576.88
▲ +4,331.91% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for GSK in the last 3 months. The average price target is $1,576.88, with a high forecast of $1,850.00 and a low forecast of $1,400.00. The average price target represents a 4,331.91% upside from the last price of $35.58.
Current Consensus is
The current consensus among 11 polled investment analysts is to hold stock in GSK. This Hold consensus rating has held steady for over two years.
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations, Research and Development, and Consumer Healthcare. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.